Clinical Trials on Uveitis, Intermediate in Canada
Total 37 results
-
CHU de Quebec-Universite LavalCompletedIntermediate Uveitis | Anterior UveitisCanada
-
AllerganCompletedPosterior Uveitis | Intermediate UveitisFrance, United Kingdom, United States, Spain, Poland, India, South Africa, Korea, Republic of, Canada, Czech Republic, Australia, Germany, Israel, Switzerland, Portugal, Austria, Brazil, Greece
-
Ottawa Hospital Research InstituteRecruiting
-
Lux Biosciences, Inc.CompletedPanuveitis | Uveitis, Posterior | Uveitis, IntermediateUnited States, United Kingdom, Canada, Germany, Austria, France, India
-
Lux Biosciences, Inc.CompletedPanuveitis | Uveitis, Posterior | Uveitis, IntermediateUnited States, United Kingdom, Canada, Germany, Austria, France, India
-
Lux Biosciences, Inc.CompletedUveitis, Anterior | PanuveitisUnited Kingdom, Canada, United States, Germany, Austria, France, India
-
Gilead SciencesGalapagos NVTerminatedNoninfectious UveitisUnited States, Israel, United Kingdom, Germany, Australia, Canada, New Zealand
-
Lux Biosciences, Inc.CompletedNoninfectious UveitisFrance, United States, Italy, Germany, Canada, United Kingdom, Czech Republic, Austria, Brazil
-
NovartisWithdrawnUveitisIsrael, United States, Switzerland, Canada, Japan
-
University Health Network, TorontoClinical Laserthermia Systems ABUnknownProstate Cancer | Low and Intermediate Risk Prostate CancerCanada
-
Hospital San Carlos, MadridRecruiting
-
InSightecCompletedLocalized Low-Intermediate Risk Prostate CancerUnited Kingdom, Israel, Canada, Italy, Singapore
-
JHSPH Center for Clinical TrialsActive, not recruitingUveitisUnited States, United Kingdom, Australia, Canada
-
Novartis PharmaceuticalsTerminatedUveitisJapan, Spain, Egypt, Switzerland, Israel, Germany, Hungary, United States, France, Singapore, United Kingdom, Canada, India
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaActive, not recruitingLow or Intermediate Risk Prostate CancerCanada
-
XOMA (US) LLCInstitut de Recherches Internationales ServierTerminatedUveitisUnited States, France, Germany, Poland, United Kingdom, China, Spain, Mexico, Portugal, Turkey, Israel, Canada, South Africa, Taiwan, Argentina, Russian Federation, Australia, Italy, Brazil, Armenia, Greece, Tunisia
-
Brigham and Women's HospitalCompletedKnown CAD, or Intermediate-high Pretest Likelihood for CADUnited States, Canada
-
XOMA (US) LLCInstitut de Recherches Internationales ServierTerminatedUveitisUnited States, France, Germany, Poland, United Kingdom, China, Spain, Mexico, Portugal, Turkey, Israel, Korea, Republic of, South Africa, Taiwan, Argentina, Brazil, Austria, Russian Federation, Australia, Armenia, Greece, Tunisia
-
Dr. Carl J BrownCanadian Association of General SurgeonsCompleted
-
Forma Therapeutics, Inc.RecruitingVery Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-RUnited States, France, Canada, Germany
-
HealthCore-NERINational Heart, Lung, and Blood Institute (NHLBI)CompletedThalassemiaUnited States, Canada
-
JHSPH Center for Clinical TrialsNational Eye Institute (NEI)CompletedUveitis | Macular EdemaUnited States, Canada, United Kingdom, Australia
-
JHSPH Center for Clinical TrialsNational Eye Institute (NEI)CompletedUveitis | Macular EdemaUnited States, Australia, Canada, India, United Kingdom
-
Alimentiv Inc.SuspendedUlcerative Colitis | PouchitisUnited States, Canada, Netherlands
-
Phoenicia BioScienceNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSickle Cell Disease | Beta Thalassemia IntermediaUnited States, Canada
-
Editas Medicine, Inc.RecruitingHemoglobinopathies | Thalassemia Major | Thalassemia Intermedia | Transfusion Dependent Beta ThalassemiaUnited States, Canada
-
Galena Biopharma, Inc.CompletedBreast Cancer With Low to Intermediate HER2 ExpressionUnited States, United Kingdom, France, Israel, Germany, Canada, Russian Federation, Romania, Bulgaria, Czech Republic, Hungary, Poland, Ukraine
-
TakedaCompletedPouchitisUnited States, Spain, United Kingdom, Canada, Germany, Netherlands, Italy, Belgium, France
-
Instituto de Investigacion Sanitaria La FeCompletedLOW AND INTERMEDIATE PAEDIATRIC NEUROBLASTOMA AND NEONATAL SUPRARENAL MASSESSpain, Italy, Belgium, Denmark, Sweden, Norway, Israel, Switzerland, Australia, Austria
-
FibroGenAstraZeneca; Astellas Pharma IncTerminatedPrimary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)United States, Australia, Belgium, Germany, Israel, Italy, Korea, Republic of, Russian Federation, Spain, United Kingdom, France, Turkey, Canada, Denmark, India, Poland
-
Hoffmann-La RocheRecruitingUveitic Macular EdemaUnited States, Korea, Republic of, United Kingdom, China, Netherlands, Canada, Israel, Austria, Brazil, Italy, Taiwan, Poland, Portugal, Mexico
-
Applied Molecular TransportCompletedPouchitisUnited States, Canada, France, Spain, United Kingdom, Germany, Belgium, Hungary, Netherlands, Switzerland
-
Ozlem SahinUnknownTuberculosis | SarcoidosisTurkey
-
Atlantic Pharmaceuticals LtdCompletedPouchitisUnited States, Belgium, Canada, France, Ireland, Israel, Italy, Netherlands, Switzerland, United Kingdom
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedB-cell Childhood Acute Lymphoblastic Leukemia | L1 Childhood Acute Lymphoblastic Leukemia | L2 Childhood Acute Lymphoblastic Leukemia | Intermediate Risk Recurrent Childhood Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, Switzerland
-
Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia (AML) | Metastatic Colorectal Cancer (mCRC) | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Relapsed/Refractory Multiple Myeloma (RRMM) | Higher-Risk Myelodysplastic Syndrome (HR-MDS) | Newly Diagnosed Intermediate/High-Risk MDSUnited States, France, Canada, Spain, China